相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Metastatic pancreatic neuroendocrine tumors (pNET): Placing current findings into perspective
Alexandria T. Phan
CANCER TREATMENT REVIEWS (2013)
Treatment of Gastroenteropancreatic Neuroendocrine Tumors with Peptide Receptor Radionuclide Therapy
Esther I. van Vliet et al.
NEUROENDOCRINOLOGY (2013)
Translation of Molecular Pathways into Clinical Trials of Neuroendocrine Tumors
Marianne Pavel
NEUROENDOCRINOLOGY (2013)
First-line treatment of patients with disseminated poorly differentiated neuroendocrine carcinomas with carboplatin, etoposide, and vincristine: A single institution experience
Ingrid Holst Olsen et al.
ACTA ONCOLOGICA (2012)
Integrating Radioembolization With Chemotherapy in the Treatment Paradigm for Unresectable Colorectal Liver Metastases
Harpreet Wasan et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2012)
Lymph Nodes and Survival in Pancreatic Neuroendocrine Tumors
Geoffrey W. Krampitz et al.
ARCHIVES OF SURGERY (2012)
Radioembolization of Symptomatic, Unresectable Neuroendocrine Hepatic Metastases Using Yttrium-90 Microspheres
Philipp M. Paprottka et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2012)
New Strategies for Advanced Neuroendocrine Tumors in the Era of Targeted Therapy
Mei Dong et al.
CLINICAL CANCER RESEARCH (2012)
Neuroendocrine tumors of the digestive tract: impact of new classifications and new agents on therapeutic approaches
Kjell Oberg
CURRENT OPINION IN ONCOLOGY (2012)
Novel Medical Therapies of Recurrent and Metastatic Gastroenteropancreatic Neuroendocrine Tumors
M. D. Miljkovic et al.
DIGESTIVE DISEASES AND SCIENCES (2012)
Therapy innovation for the treatment of pancreatic neuroendocrine tumors
Ferdinando Riccardi et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2012)
Management of Pancreatic Neuroendocrine Tumors
Daniel M. Halperin et al.
GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2012)
US-guided ethanol ablation of insulinomas: a new treatment option
Michael J. Levy et al.
GASTROINTESTINAL ENDOSCOPY (2012)
Radioembolization for Neuroendocrine Liver Metastases: Safety, Imaging, and Long-Term Outcomes
Khairuddin Memon et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Phase II study of sunitinib (SU) in Japanese patients with unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumor (NET).
Takuji Okusaka et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Molecular pathology and genetics of pancreatic endocrine tumours
Gabriele Capurso et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2012)
TNM Staging of Neoplasms of the Endocrine Pancreas: Results From a Large International Cohort Study
G. Rindi et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Well-differentiated pancreatic neuroendocrine tumors: from genetics to therapy
Roeland F. de Wilde et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2012)
ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms of the Digestive System: Well-Differentiated Pancreatic Non-Functioning Tumors
Massimo Falconi et al.
NEUROENDOCRINOLOGY (2012)
ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms: Functional Pancreatic Endocrine Tumor Syndromes
Robert T. Jensen et al.
NEUROENDOCRINOLOGY (2012)
ENETS Consensus Guidelines for the Management of Patients with Liver and Other Distant Metastases from Neuroendocrine Neoplasms of Foregut, Midgut, Hindgut, and Unknown Primary
Marianne Pavel et al.
NEUROENDOCRINOLOGY (2012)
Hepatic Artery Embolization for Neuroendocrine Tumors: Postprocedural Management and Complications
Mark A. Lewis et al.
ONCOLOGIST (2012)
Antitumor Effects of Somatostatin Analogs in Neuroendocrine Tumors
Lucas Sideris et al.
ONCOLOGIST (2012)
Predictors of response to radio-embolization (TheraSphere (R)) treatment of neuroendocrine liver metastasis
Mohammed Shaheen et al.
HPB (2012)
A Multimodal Approach to the Management of Neuroendocrine Tumour Liver Metastases
Ron Basuroy et al.
INTERNATIONAL JOURNAL OF HEPATOLOGY (2012)
Implications of Incidentally Discovered, Nonfunctioning Pancreatic Endocrine Tumors Short-term and Long-term Patient Outcomes
Alex B. Haynes et al.
ARCHIVES OF SURGERY (2011)
Pancreatic Endocrine Tumors With Major Vascular Abutment, Involvement, or Encasement and Indication for Resection
Jeffrey A. Norton et al.
ARCHIVES OF SURGERY (2011)
First-Line Chemotherapy With Capecitabine and Temozolomide in Patients With Metastatic Pancreatic Endocrine Carcinomas
Jonathan R. Strosberg et al.
CANCER (2011)
Therapy innovations: tyrosine kinase inhibitors for the treatment of pancreatic neuroendocrine tumors
Eric Raymond et al.
CANCER AND METASTASIS REVIEWS (2011)
Intra-Arterial Treatment with 90Yttrium Microspheres in Treatment-Refractory and Unresectable Liver Metastases of Neuroendocrine Tumors and the Use of 111In-Octreotide Scintigraphy in the Evaluation of Treatment Response
Seda Lacin et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2011)
New therapeutic options for metastatic malignant insulinomas
Wouter W. de Herder et al.
CLINICAL ENDOCRINOLOGY (2011)
New Treatment Options for Patients with Advanced Neuroendocrine Tumors
Jennifer A. Chan et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2011)
Ki-67 index, tumor differentiation, and extent of liver involvement are independent prognostic factors in patients with liver metastases of digestive endocrine carcinomas
O. Hentic et al.
ENDOCRINE-RELATED CANCER (2011)
Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms
Guenter Kloeppel
ENDOCRINE-RELATED CANCER (2011)
Somatostatin Receptor-Targeted Radionuclide Therapy in Patients with Gastroenteropancreatic Neuroendocrine Tumors
Dik J. Kwekkeboom et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2011)
Novel Therapeutic Agents for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors
M. E. Pavel et al.
HORMONE AND METABOLIC RESEARCH (2011)
Future Directions in the Treatment of Neuroendocrine Tumors: Consensus Report of the National Cancer Institute Neuroendocrine Tumor Clinical Trials Planning Meeting
Matthew H. Kulke et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Everolimus versus placebo in Japanese patients with advanced pancreatic neuroendocrine tumors (pNET): Japanese subgroup analysis of RADIANT-3
T. Ito et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Metastatic and Locally Advanced Pancreatic Endocrine Carcinomas: Analysis of Factors Associated With Disease Progression
Francesco Panzuto et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Evolving Diagnostic and Treatment Strategies for Pancreatic Neuroendocrine Tumors
Matthew H. Kulke et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2011)
68Ga-DOTATOC PET/CT of Neuroendocrine Tumors: Spotlight on the CT Phases of a Triple-Phase Protocol
Juri Ruf et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study
Marianne E. Pavel et al.
LANCET (2011)
68Ga-DOTA-NOC PET/CT Imaging of Neuroendocrine Tumors: Comparison with 111In-DTPA-Octreotide (OctreoScan®)
Yodphat Krausz et al.
MOLECULAR IMAGING AND BIOLOGY (2011)
Promising Advances in the Treatment of Malignant Pancreatic Endocrine Tumors.
Robert T. Jensen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors.
Eric Raymond et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Everolimus for Advanced Pancreatic Neuroendocrine Tumors.
James C. Yao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Transarterial Chemoembolization and Selective Internal Radiation for the Treatment of Patients with Metastatic Neuroendocrine Tumors: A Comparison of Efficacy and Cost
Ryan Whitney et al.
ONCOLOGIST (2011)
Targeted Therapy in Advanced Well-Differentiated Neuroendocrine Tumors
Chandrajit P. Raut et al.
ONCOLOGIST (2011)
Everolimus Induces Rapid Plasma Glucose Normalization in Insulinoma Patients by Effects on Tumor As Well As Normal Tissues
Helle-Brit Fiebrich et al.
ONCOLOGIST (2011)
Pancreatic endocrine tumors or apudomas
Modesto Varas et al.
REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS (2011)
DAXX/ATRX, MEN1, and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors
Yuchen Jiao et al.
SCIENCE (2011)
Multimodality treatment of neuroendocrine liver metastases
Koray Karabulut et al.
SURGERY (2011)
Curative resection of a huge malignant pancreatic endocrine tumor by pancreatoduodenectomy with portal and superior mesenteric vein resection and reconstruction using the right ovarian vein: Report of a case
Takanori Ochiai et al.
SURGERY TODAY (2011)
Radioembolization in the Treatment of Neuroendocrine Tumor Metastases to the Liver
Martin Vyleta et al.
INTERNATIONAL JOURNAL OF HEPATOLOGY (2011)
Treatment of Liver Metastases in Patients with Neuroendocrine Tumors: A Comprehensive Review
Theresa R. Harring et al.
INTERNATIONAL JOURNAL OF HEPATOLOGY (2011)
Nordic Guidelines 2010 for diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours
Eva Tiensuu Janson et al.
ACTA ONCOLOGICA (2010)
Clinicopathological Features of Pancreatic Endocrine Tumors: A Prospective Multicenter Study in Italy of 297 Sporadic Cases
Alessandro Zerbi et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Pathology Reporting of Neuroendocrine Tumors: Application of the Delphic Consensus Process to the Development of a Minimum Pathology Data Set
David S. Klimstra et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2010)
Management of Intractable Hypoglycemia With Yttirum-90 Radioembolization in a Patient With Malignant Insulinoma
Prakash Chandra et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2010)
Factors Predicting Response and Survival After Yttrium-90 Radioembolization of Unresectable Neuroendocrine Tumor Liver Metastases A Critical Appraisal of 48 Cases
Akshat Saxena et al.
ANNALS OF SURGERY (2010)
Radioembolization (Yttrium-90 Microspheres) for Primary and Metastatic Hepatic Malignancies
Andrew S. Kennedy et al.
CANCER JOURNAL (2010)
Biological targeted therapies in patients with advanced enteropancreatic neuroendocrine carcinomas
Nicola Fazio et al.
CANCER TREATMENT REVIEWS (2010)
Regulatory Peptides from Chromogranin A and Secretogranin II
Karen B. Helle
CELLULAR AND MOLECULAR NEUROBIOLOGY (2010)
New drugs in neuroendocrine tumors: rising of new therapeutic philosophies?
Barbro Eriksson
CURRENT OPINION IN ONCOLOGY (2010)
Somatostatin receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors
Dik J. Kwekkeboom et al.
ENDOCRINE-RELATED CANCER (2010)
Gastroenteropancreatic neuroendocrine tumours: the current incidence and staging based on the WHO and European Neuroendocrine Tumour Society classification: an analysis based on prospectively collected parameters
Martin B. Niederle et al.
ENDOCRINE-RELATED CANCER (2010)
Novel Anticancer Agents in Clinical Trials for Well-Differentiated Neuroendocrine Tumors
Sandrine Faivre et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2010)
Therapies for the medical management of persistent hypoglycaemia in two cases of inoperable malignant insulinoma
Gregory S. Y. Ong et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2010)
State of the art: radiolabeled microspheres treatment for liver malignancies
Deleporte Amelie et al.
EXPERT OPINION ON PHARMACOTHERAPY (2010)
Role of Somatostatins in Gastroenteropancreatic Neuroendocrine Tumor Development and Therapy
Kjell E. Oberg et al.
GASTROENTEROLOGY (2010)
Long-Term Suppressive Effect of Octreotide on Progression of Metastatic Gastrinoma with Multiple Endocrine Neoplasia Type 1: Seven-Year Follow up
Megu Yamaguchi et al.
INTERNAL MEDICINE (2010)
Cisplatin and Etoposide as First-line Chemotherapy for Poorly Differentiated Neuroendocrine Carcinoma of the Hepatobiliary Tract and Pancreas
Satoru Iwasa et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2010)
Pancreatic Endocrine Tumors: Expression Profiling Evidences a Role for AKT-mTOR Pathway
Edoardo Missiaglia et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine tumours, current aspects and new perspectives
Marialuisa Appetecchia et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2010)
Epidemiological study of gastroenteropancreatic neuroendocrine tumors in Japan
Tetsuhide Ito et al.
JOURNAL OF GASTROENTEROLOGY (2010)
Pancreatic endocrine tumors: improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patients
Aldo Scarpa et al.
MODERN PATHOLOGY (2010)
ENETS Consensus Guidelines for the Management of Peritoneal Carcinomatosis from Neuroendocrine Tumors
Reza Kianmanesh et al.
NEUROENDOCRINOLOGY (2010)
ENETS Consensus Guidelines for the Management of Bone and Lung Metastases from Neuroendocrine Tumors
Beata Kos-Kudla et al.
NEUROENDOCRINOLOGY (2010)
Impact of Multiphase Ga-68-DOTATOC-PET/CT on Therapy Management in Patients with Neuroendocrine Tumors
Juri Ruf et al.
NEUROENDOCRINOLOGY (2010)
NANETS Treatment Guidelines Well-Differentiated Neuroendocrine Tumors of the Stomach and Pancreas
Matthew H. Kulke et al.
PANCREAS (2010)
The NANETS Consensus Guidelines for the Diagnosis and Management of Poorly Differentiated (High-Grade) Extrapulmonary Neuroendocrine Carcinomas
Jonathan R. Strosberg et al.
PANCREAS (2010)
The Pathologic Classification of Neuroendocrine Tumors A Review of Nomenclature, Grading, and Staging Systems
David S. Klimstra et al.
PANCREAS (2010)
Survival following resection of pancreatic endocrine tumors: importance of R-status and the WHO and TNM classification systems
Ewa Pomianowska et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2010)
Transarterial Liver-Directed Therapies of Neuroendocrine Hepatic Metastases
Javier Nazario et al.
SEMINARS IN ONCOLOGY (2010)
Laparoscopic radiofrequency thermal ablation of neuroendocrine hepatic metastases: Long-term follow-up
Hizir Yakup Akyildiz et al.
SURGERY (2010)
Neuroendocrine Liver Metastases
Srinevas K. Reddy et al.
SURGICAL CLINICS OF NORTH AMERICA (2010)
Liver transplantation for primary or secondary endocrine tumors
Emilie Gregoire et al.
TRANSPLANT INTERNATIONAL (2010)
Recent standardization of treatment strategy for pancreatic neuroendocrine tumors
Masayuki Imamura
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
Antiproliferative effect of somatostatin analogs in gastroenteropancreatic neuroendocrine tumors
Jonathan Strosberg et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
Review article: future therapies for management of metastatic gastroenteropancreatic neuroendocrine tumours
R. Srirajaskanthan et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
O-6-Methylguanine DNA Methyltransferase Deficiency and Response to Temozolomide-Based Therapy in Patients with Neuroendocrine Tumors
Matthew H. Kulke et al.
CLINICAL CANCER RESEARCH (2009)
Molecular target therapy for gastroenteropancreatic endocrine tumours: Biological rationale and clinical perspectives
Gabriele Capurso et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2009)
Primary tumour resection in metastatic nonfunctioning pancreatic endocrine carcinomas
R. Bettini et al.
DIGESTIVE AND LIVER DISEASE (2009)
Combined liver surgery and RFA for patients with gastroenteropancreatic endocrine tumors presenting with more than 15 metastases to the liver
D. Elias et al.
EJSO (2009)
Prognostic factors influencing survival from metastatic (stage IV) gastroenteropancreatic well-differentiated endocrine carcinoma
Cosimo Durante et al.
ENDOCRINE-RELATED CANCER (2009)
Liver metastases of neuroendocrine carcinomas: Interventional treatment via transarterial embolization, chemoembolization and thermal ablation
Thomas J. Vogl et al.
EUROPEAN JOURNAL OF RADIOLOGY (2009)
The role of arterial stimulation and simultaneous venous sampling in addition to cross-sectional imaging for localisation of biochemically proven insulinoma
D. L. Morganstein et al.
EUROPEAN RADIOLOGY (2009)
Somatostatin analog octreotide LAR (R) in gastro-entero-pancreatic tumors
Kjell Oberg
EXPERT REVIEW OF ANTICANCER THERAPY (2009)
Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
Anja Rinke et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Bone Metastases in Patients with Neuroendocrine Tumor: 68Ga-DOTA-Tyr3-Octreotide PET in Comparison to CT and Bone Scintigraphy
Daniel Putzer et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Role of Interventional Radiology in the Treatment of Patients with Neuroendocrine Metastases in the Liver
Larry K. Kvols et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2009)
Peptide-receptor radionuclide therapy for endocrine tumors
Martijn van Essen et al.
NATURE REVIEWS ENDOCRINOLOGY (2009)
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Biotherapy
Kjell Oberg et al.
NEUROENDOCRINOLOGY (2009)
Survival and Prognostic Factor Analysis of 146 Metastatic Neuroendocrine Tumors of the Mid-Gut
Jonathan Strosberg et al.
NEUROENDOCRINOLOGY (2009)
Temozolomide: A Safe and Effective Treatment for Malignant Digestive Endocrine Tumors
Frederique Maire et al.
NEUROENDOCRINOLOGY (2009)
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological Examinations
Anders Sundin et al.
NEUROENDOCRINOLOGY (2009)
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Chemotherapy in Patients with Neuroendocrine Tumors
Barbro Eriksson et al.
NEUROENDOCRINOLOGY (2009)
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Somatostatin Receptor Imaging with In-111-Pentetreotide
Dik J. Kwekkeboom et al.
NEUROENDOCRINOLOGY (2009)
Glycemic Control in Patients with Insulinoma Treated with Everolimus
Matthew H. Kulke et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Is adjuvant therapy with streptozotocin and 5-fluorouracil useful after resection of liver metastases from digestive endocrine tumors?
Frederique Maire et al.
SURGERY (2009)
World Health Organization Classification (2004)-based Re-evaluation of 95 nonfunctioning malignant pancreatic endocrine tumors reported in Japan
Asuka Tsuchiya et al.
SURGERY TODAY (2009)
Molecular targeted therapies in the treatment of gastroenteropancreatic neuroendocrine tumors
Jaume Capdevila et al.
TARGETED ONCOLOGY (2009)
Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres:: Early results in 148 patients
Andrew S. Kennedy et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2008)
Predictors of long-term survival after liver transplantation for metastatic endocrine tumors:: An 85-case french multicentric report
Y. P. Le Treut et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2008)
Prognostic factors at diagnosis and value of WHO classification in a mono-institutional series of 180 non-functioning pancreatic endocrine tumours
R. Bettini et al.
ANNALS OF ONCOLOGY (2008)
Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival
T. R. Halfdanarson et al.
ANNALS OF ONCOLOGY (2008)
90Y radioembolization for metastatic neuroendocrine liver tumors -: Preliminary results from a multi-institutional experience
Thomas K. Rhee et al.
ANNALS OF SURGERY (2008)
Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors
Ulrich-Frank Pape et al.
CANCER (2008)
Radioembolization with selective internal radiation microspheres for neuroendocrine liver metastases
Julie King et al.
CANCER (2008)
Prognostic Factors and Survival in 324 Patients with Pancreatic Endocrine Tumor Treated at a Single Institution
Sara Ekeblad et al.
CLINICAL CANCER RESEARCH (2008)
Short- and long-term somatostatin analogue treatment in patients with hypoglycaemia related to endogenous hyperinsulinism
D. Vezzosi et al.
CLINICAL ENDOCRINOLOGY (2008)
Plasma chromogranin A as marker for survival in patients with metastatic endocrine gastroenteropancreatic tumors
Rudolf Arnold et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
Regression of a large malignant gastrinoma on treatment with Sandostatin LAR (R): A case report
Dan Granberg et al.
DIGESTION (2008)
Gastrointestinal Neuroendocrine Tumors: Pancreatic Endocrine Tumors
David C. Metz et al.
GASTROENTEROLOGY (2008)
Targeting vascular endothelial growth factor in advanced carcinoid tumor: A random assignment phase II study of depot octreotide with bevacizumab and pegylated interferon alfa-2b
James C. Yao et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Efficacy of RAD001 (everolimus) and octreotide LAR in advanced low- to intermediate-grade neuroendocrine tumors: Results of a phase II study
James C. Yao et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
One hundred years after Carcinoid: Epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States
James C. Yao et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Treatment with the radiolabeled somatostatin analog [177Lu-DOTA0, Tyr3] octreotate:: Toxicity, efficacy, and survival
Dik J. Kwekkeboom et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Activity of sunitinib in patients with advanced neuroendocrine tumors
Matthew H. Kulke et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Yttrium-90 microsphere radioembolotherapy of hepatic metastatic neuroendocrine carcinomas after hepatic arterial embolization
Ravi Murthy et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2008)
Gastroenteropancreatic neuroendocrine tumours
Irvin M. Modlin et al.
LANCET ONCOLOGY (2008)
Surgery and radiofrequency ablation for treatment of liver metastases from midgut and foregut carcinoids and endocrine pancreatic tumors
John Eriksson et al.
WORLD JOURNAL OF SURGERY (2008)
Consensus guidelines for the management of patients with liver metastases from digestive (neuro) endocrine tumors: Foregut, midgut, hindgut, and unknown primary
Thomas Steinmueller et al.
NEUROENDOCRINOLOGY (2008)
Population-based study of islet cell carcinoma
James C. Yao et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
WHO 2004 criteria and CK19 are reliable prognostic markers in pancreatic endocrine tumors
Ania M. Schmitt et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2007)
Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours
I. Buchmann et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2007)
Laparoscopic radiofrequency ablation of neuroendocrine liver metastases: a 10-year experience evaluating predictors of survival
Peter J. Mazzaglia et al.
SURGERY (2007)
Temozolomide as monotherapy is effective in treatment of advanced malignant neuroendocrine tumors
Sara Ekeblad et al.
CLINICAL CANCER RESEARCH (2007)
Orthotopic liver or multivisceral transplantation as treatment of metastatic neuroendocrine tumors
Michael Olausson et al.
LIVER TRANSPLANTATION (2007)
Cytotoxic treatment including embolization/chemoembolization for neuroendocrine tumours
Christos Toumpanakis et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Molecular targeted therapy for carcinoid and islet-cell carcinoma
James C. Yao
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Tumour biology and histopathology of neuroendocrine tumours
Guenter Kloeppel
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Peptide receptor radionuclide therapy
Flavio Forrer et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Pancreatic Endocrine Tumors with Intraductal Growth into the Main Pancreatic Duct and Tumor Thrombus within the Portal Vein: A Case Report and Review of the Literature
Hiroshi Kawakami et al.
INTERNAL MEDICINE (2007)
Survival from malignant digestive endocrine tumors in England and Wales: A population-based study
Come Lepage et al.
GASTROENTEROLOGY (2007)
Biotherapy
U. Ploeckinger et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Predictive factors of efficacy of the somatostatin analogue octreotide as first line therapy for advanced pancreatic endocrine carcinoma
G. Butturini et al.
ENDOCRINE-RELATED CANCER (2006)
A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas
I. Duran et al.
BRITISH JOURNAL OF CANCER (2006)
TNM staging of foregut (neuro)endocrine tumors:: a consensus proposal including a grading system
G. Rindi et al.
VIRCHOWS ARCHIV (2006)
Phase II trial of paclitaxel, carboplatin, and etoposide in advanced poorly differentiated neuroendocrine carcinoma: A Minnie Pearl Cancer Research Network Study
John D. Hainsworth et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
EUS-guided alcohol ablation of an insulinoma
C Jürgensen et al.
GASTROINTESTINAL ENDOSCOPY (2006)
Alkaline phosphatase predicts survival in patients with metastatic neuroendocrine tumors
Thomas E. Clancy et al.
DIGESTIVE DISEASES AND SCIENCES (2006)
Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumors
DA Osborne et al.
ANNALS OF SURGICAL ONCOLOGY (2006)
Long-term clinical outcome of somatostatin analogues for treatment of progressive, metastatic, well-differentiated entero-pancreatic endocrine carcinoma
F Panzuto et al.
ANNALS OF ONCOLOGY (2006)
Phase II study of temozolomide and thalidomide in patients with metastatic neuroendocrine tumors
MH Kulke et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Patients with multiple endocrine neoplasia type 1 with gastrinomas have an increased risk of severe esophageal disease including stricture and the premalignant condition, Barrett's esophagus
KM Hoffmann et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Poorly differentiated carcinomas of the foregut (gastric, duodenal and pancreatic)
Ola Nilsson et al.
NEUROENDOCRINOLOGY (2006)
Gastrinoma (duodenal and pancreatic)
Robert T. Jensen et al.
NEUROENDOCRINOLOGY (2006)
Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization
F Panzuto et al.
ENDOCRINE-RELATED CANCER (2005)
Endocrine tumours of the pancreas
K Öberg et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2005)
Transplantation in the management of metastatic endocrine tumours
A Pascher et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2005)
Chemoembolization and other ablative therapies for liver metastases of gastrointestinal endocrine tumours
D O'Toole et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2005)
Octreotide versus octreotide plus interferon-alpha in endocrine gastroenteropancreatic tumors:: A randomized trial
R Arnold et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2005)
Somatostatin receptors as tools for diagnosis and therapy: Molecular aspects
J Guillermet-Guibert et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2005)
Octreotide in insulinoma patients: efficacy on hypoglycemia, relationships with Octreoscan scintigraphy and immunostaining with anti-sst2A and anti-sstS antibodies
D Vezzosi et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2005)
Increased expression of insulin-like growth factor I and/or its receptor in gastrinomas is associated with low curability, increased growth, and development of metastases
M Furukawa et al.
CLINICAL CANCER RESEARCH (2005)
Radiolabeled somatostatin analog [177Lu-DOTA0,Tyr3] octreotate in patients with endocrine gastroenteropancreatic tumors
DJ Kwekkeboom et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Diagnostic uses of radiolabelled somatostatin receptor analogues in gastroenteropancreatic endocrine tumours
F Gibril et al.
DIGESTIVE AND LIVER DISEASE (2004)
Fluorouracil, doxorubicin, and streptozocin in the treatment of patients with locally advanced and metastatic pancreatic endocrine carcinomas
MA Kouvaraki et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Aggressive surgery for metastatic liver neuroendocrine tumors
JA Norton et al.
SURGERY (2003)
Experience with indium-111 and yttrium-90-labeled somatostatin analogs
I Virgolini et al.
CURRENT PHARMACEUTICAL DESIGN (2002)
Nonfunctioning islet cell carcinoma of the pancreas: Survival results in a contemporary series of 163 patients
CC Solorzano et al.
SURGERY (2001)
Surgical strategy for large or malignant endocrine pancreatic tumors
P Hellman et al.
WORLD JOURNAL OF SURGERY (2000)
Hepatic neuroendocrine metastases: Does intervention alter outcomes?
RS Chamberlain et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2000)
分享论文
